Privacy-sensitive practices (psychiatry, therapy, addiction, STI clinics) struggle to build public reviews because patients don't want to be publicly associated with the practice.
Aggregates anonymized internal patient satisfaction scores and displays verified, HIPAA-compliant trust badges and anonymized testimonials on the practice's Google profile, website, and directory listings. Patients opt-in to share anonymized feedback publicly.
Subscription - $49-149/month per practice location
This is a top-of-mind, visceral pain. Direct quotes from practitioners: 'only 20 Google reviews in 3 years,' 'patients don't want others knowing they come to us.' Therapist and psychiatry forums consistently rank review generation as their #1 marketing challenge. The asymmetry is structural — happy patients stay silent due to stigma, unhappy ones occasionally post, creating a permanently distorted public profile. This isn't a nice-to-have; practices are losing new patients to competitors with better (but possibly less deserved) online reputations.
Narrow but deep. Approximately 120K+ mental health practices in the US, 15K+ addiction treatment centers, 30K+ sensitive legal practices (divorce/criminal defense). At $99/month average, that's ~$200M TAM for core segments. Expanding to reproductive health, STI clinics, plastic surgery, and other stigma-adjacent services could push toward $400M+. Not a billion-dollar TAM on its own, but large enough to build a very profitable business. The concern is that this is a niche within healthcare — not a weakness per se, but it caps venture-scale outcomes.
Practices already pay $100-1,000/month for reputation tools that don't work well for them. The $49-149/month price point is well below what they're currently wasting on Birdeye/Podium-style tools that generate zero results for sensitive practices. A practice acquiring even one new patient per month from better trust signals would see 10-50x ROI on the subscription. The constraint: many solo therapists are cost-conscious and skeptical of marketing tools after being burned by generic solutions.
Core MVP is straightforward: patient survey collection (email/SMS), anonymization/aggregation engine, embeddable badge/widget, basic dashboard. No ML required for V1. HIPAA compliance adds complexity (BAAs, encryption, audit logs, hosting requirements) but is well-documented territory with established infrastructure (AWS HIPAA-eligible services, compliant email providers). A solo dev with healthcare SaaS experience could ship MVP in 6-8 weeks. The Google Business Profile integration (displaying trust signals) is the trickiest technical piece — may require working within Google's structured data or review API constraints.
This is genuine whitespace. Existing players fall into two non-overlapping camps: (1) public review generators that actively harm sensitive practices, and (2) internal survey tools that never surface data publicly. Nobody bridges internal satisfaction data to public trust signals with a privacy-preserving layer. Incumbents are structurally disincentivized from building this — Birdeye and Podium's entire value proposition is 'more public reviews,' and pivoting to 'anonymous aggregate scores' would confuse their positioning. The regulatory complexity (HIPAA, professional ethics codes) creates a genuine moat that generic tools won't casually cross.
Near-perfect subscription fit. Trust signals must be continuously updated to remain credible (stale scores lose value). New patient feedback flows in monthly. Practices need ongoing badge display, dashboard access, and integration maintenance. Churn risk is low once embedded — removing the badge/trust signal from your website and listings creates a visible trust gap. Expansion revenue per account is natural: additional locations, premium badge tiers, directory listings, response management features.
- +Genuine whitespace — no product bridges internal satisfaction to public trust for sensitive practices
- +Structural pain that existing tools cannot solve without contradicting their own business model
- +Strong regulatory moat — HIPAA, APA/AMA ethics codes, and state privacy laws deter casual competitors
- +Low price point relative to value delivered — one new patient per month pays for the tool 10-50x over
- +Natural expansion path from mental health to addiction, legal, reproductive health, and other stigma-adjacent verticals
- +High retention dynamics — removing the trust signal once displayed creates visible credibility loss
- !Badge credibility chicken-and-egg: the trust signal is only valuable if patients and the public recognize and trust the PrivateProof brand, which takes time to build
- !Google integration uncertainty: displaying trust signals on Google Business Profiles may be constrained by Google's policies; if Google changes rules, a core distribution channel is at risk
- !HIPAA compliance overhead: BAAs, security audits, encryption requirements, and breach notification obligations add real cost and legal exposure for a bootstrapped startup
- !Niche market ceiling: if expansion beyond mental health proves slower than expected, the TAM may be too small for venture-scale returns (though perfectly viable as a profitable bootstrapped business)
- !Practice inertia: many small practices are slow to adopt new tools, creating long sales cycles and high customer acquisition costs
- !Ethical/regulatory gray area: some licensing boards may view aggregated-but-anonymized patient feedback as still constituting testimonials, requiring careful navigation of professional ethics rules
Automated patient satisfaction surveys with EHR integration that funnels satisfied patients to leave public Google/Healthgrades reviews. Closest competitor in the small-practice healthcare reputation space.
All-in-one reputation management platform covering review solicitation, monitoring, response, listings management, and SEO across multiple verticals including healthcare.
HIPAA-compliant patient satisfaction survey platform that collects post-visit feedback and generates internal analytics and benchmarking for practices.
All-in-one practice growth platform bundling reputation management, website builder, SEO, patient engagement, billing, and online scheduling.
The largest doctor rating and review platform where patients leave public reviews and doctors can claim/enhance their profiles with appointment booking integration.
HIPAA-compliant patient satisfaction survey (email/SMS post-visit) → anonymization engine that strips PII and aggregates scores → embeddable trust badge showing verified satisfaction score + anonymized testimonial snippets → simple practice dashboard. Start with a Webflow landing page, manual onboarding for first 10 practices, and a basic widget. Skip Google profile integration for V1 — focus on the practice's own website badge as proof of concept. Use one specialty (therapists/psychiatrists) as the beachhead.
Free pilot for 10-20 practices (3 months) to build case studies and prove lift in new patient inquiries → $49/month Starter (survey + badge + basic dashboard) → $99/month Pro (anonymized testimonials, directory syndication, multi-location) → $149/month Premium (API integrations with EHR/PM systems, custom branding, analytics) → Enterprise tier for group practices and treatment center chains ($299+ per location with volume discounts). Affiliate revenue from directory partnerships as secondary stream.
8-12 weeks to first paying customer. Weeks 1-6: build MVP (survey + anonymization + badge). Weeks 6-8: onboard 10 free pilot practices from therapist communities (r/therapists, Psychology Today forums, local therapy Facebook groups). Weeks 8-12: convert pilots to paid plans with case study data showing new patient inquiry lift. Revenue ramp: $5K MRR by month 6, $15-25K MRR by month 12 if focused on therapist/psychiatrist niche.
- “many patients dont want others knowing they come to us”
- “only had about 20 Google reviews in nearly 3 years”
- “We get some amazing reviews internally... I really wanted our public facing Google page to reflect that”
- “for psych especially, private word of mouth matters more than raw review volume”